**Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers**

**Vanessa Acebes-Fernández 1, Alicia Landeira-Viñuela 1, Pablo Juanes-Velasco 1, Angela-Patricia Hernández 1, Andrea Otazo-Perez 1, Raúl Manzano-Román 2, Rafael Gongora <sup>1</sup> and Manuel Fuentes 1,2,\***


Received: 3 June 2020; Accepted: 23 June 2020; Published: 29 June 2020

**Abstract:** The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy.

**Keywords:** nanomaterials; nanomedicine; immunotherapy; oncotherapy; immune-checkpoint inhibitors; immunogenic cell death; nano-vaccines; nano-conjugates; immune response
